Analytical Data
-
Gene name
C9orf19
- Application
-
Alternative Names
5730414A08Rik; C77180; C9orf19; GAPR 1; GAPR-1; GAPR1_HUMAN; GLI pathogenesis related 2; Glioma pathogenesis related Protein 2; Glioma pathogenesis-related Protein 2; GliPR 2
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H4G4
-
Expression Region
1-154aa
-
AA Sequence
MGKSASKQFHNEVLKAHNEYRQKHGVPPLKLCKNLNREAQQYSEALASTRILKHSPESSRGQCGENLAWASYDQTGKEVADRWYSEIKNYNFQQPGFTSGTGHFTAMVWKNTKKMGVGKASASDGSSFVVARYFPAGNVVNEGFFEENVLPPKK
-
Molecular Weight
43.6 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9orf19, or chromosome 9 open reading frame 19, is a gene that has recently gained attention in genetic and molecular biology research due to its potential implications in neurological disorders and cellular functions. The protein encoded by C9orf19 is believed to be involved in a variety of cellular processes, yet its precise biological role remains largely uncharacterized. Previous studies have indicated its potential link to conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), particularly due to its association with genetic variants in affected individuals. As researchers strive to understand the molecular mechanisms underpinning these diseases, the study of C9orf19 recombinant protein has become crucial. By producing and analyzing this protein, scientists aim to elucidate its structure, function, and interactions within the cell. This research may provide insights into how C9orf19 contributes to neuronal health and disease, ultimately aiding in the development of targeted therapies. Overall, the investigation into C9orf19 recombinant protein stands at the intersection of genetic research and neurobiology, highlighting its potential role as a biomarker or therapeutic target for neurodegenerative diseases.
